Certification Rate
99.2%
Very high DOL cert
2026 data Public-data reference Official source
Novartis Pharmaceuticals Corporation
A DOL Labor Condition Application record spanning FY2023–2026. Review the filing volume, DOL certification record, and offered-wage context below.
- DOL LCA filings
- 382
- DOL-certified
- 99.2%
- Median offered wage
- $140,503
East Hanover, NJ NAICS: 541713
How many H-1B LCA filings list Novartis Pharmaceuticals Corporation?
U.S. Department of Labor's OFLC discloses 382 Labor Condition Application filings naming Novartis Pharmaceuticals Corporation from FY2023 through FY2026, drawn directly from DOL's quarterly public disclosure releases. An LCA is the wage-and-working-conditions attestation an employer files with DOL before petitioning USCIS for an H-1B worker: it is a filing record, not a USCIS approval, a job offer, or a confirmed hire, and the count reflects filings, not people, since an employer sponsoring the same role at more than one worksite, or refiling across fiscal years, is counted once per filing. See filing history · Recent LCAs
How many H-1B petitions has USCIS approved for Novartis Pharmaceuticals Corporation?
Separate from the DOL filing record above, U.S. Citizenship and Immigration Services adjudicated 842 H-1B petitions naming Novartis Pharmaceuticals Corporation through FY2023, and approved nearly every one of them: 98.1% approved (826 approvals, 16 denials). A DOL certification is the labor-condition step filed before a petition; this USCIS figure is the actual adjudicated outcome, and the two rates commonly differ.
The verdict
Novartis Pharmaceuticals Corporation is listed in 382 DOL LCA filings, among the largest employer filers by filing volume in this extract. DOL certified 99.2% of those LCAs; the median listed offered wage is $140,503. This is not a USCIS approval, hiring, or sponsorship ranking.
- 382
- DOL LCA filings, FY2023–FY2026
- 99.2%
- DOL-certified
- $140,503
- median offered wage
- Top 1%
- of employer filers by volume
According to U.S. Department of Labor OFLC LCA disclosure files (FY2023–FY2026). Based in East Hanover, NJ.
Novartis Pharmaceuticals Corporation LCA outcome mix
382DOL LCA filings on record
Saved on this device only, no account, no email.
Open saved list
Follow this profile's data updates
Updates when the published DOL data vintage changes; this is a feed, not an alert service.
Novartis Pharmaceuticals Corporation vs all U.S. employer filers by LCA volume
Where this employer's disclosed Labor Condition Application count sits among every tracked employer filer (inventory signal, not a sponsorship ranking)
382 569th of 122824 higher than 122,255 of 122,824 employer filers
Employer filers, banded by disclosed H-1B LCA filing count
Each bar is a band; taller bars hold more employer filers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source U.S. Department of Labor OFLC · FY2023–FY2026
LCA filing shape · Novartis Pharmaceuticals Corporation
Derived from this employer's disclosed LCAs on file (FY2023–FY2026), title mix and worksite counties, not national boilerplate. LCA filings do not establish USCIS outcomes or confirmed hiring.
Offered-wage span on file: $62,629–$241,592 .
Title concentration
- Principal Biostatistician 48 · 12.6% · $121,387
- Senior Principal Biostatistician 24 · 6.3% · $128,626
- Expert Science & Technology 7 · 1.8% · $113,690
- Principal Pharmacometrician 5 · 1.3% · $110,852
- Associate Director, Biostatistics 5 · 1.3% · $162,215
Worksite counties
- MORRIS, NJ 13 · 92.9%
- DURHAM, NC 1 · 7.1%
DOL LCA release change
What changed between the two LCA fiscal years
- Novartis Pharmaceuticals Corporation's disclosed H-1B LCA filing count rose from 91 in FY2024 to 114 in FY2025 (+25.3%).
- Novartis Pharmaceuticals Corporation's average disclosed H-1B offered wage rose from $136,896 in FY2024 to $147,616 in FY2025 (+7.8%).
National-scale filing footprint
Novartis Pharmaceuticals Corporation has filed 382 LCAs (more volume than 100% of U.S. employer filers in this extract). DOL certification: 99.2%. Worksites span 3 states , led by NJ.
Avg. Salary
$140,503
Above portal avg
Total Workers
382
Moderate worker count
Compare with another employer filer
Novartis Pharmaceuticals Corporation vs a peer vs the national average, from DOL LCA data.
Avg. offered wage$140,503 · 6% lower than Ernst & Young US LLP
This filer
Peer
$149,512
National avg.
$113,357
Certification rate99.2% · 2% higher than Ernst & Young US LLP
This filer
Peer
97.6%
National avg.
97.7%
Total LCA filings382 · 99% lower than Ernst & Young US LLP
This filer
Peer
39,678
National avg.
17
FY2025 filings are 99% of FY2023
115 completed-year filings in FY2023, 114 in FY2025. The scale spans up to twice the earlier year's count: the midpoint is unchanged and the endpoint is at least doubled.
Wondering how long it takes USCIS to process an H-1B petition for this employer?
See current I-129 processing times →
Salary Analysis
Compensation range for H-1B positions at Novartis Pharmaceuticals Corporation
Minimum
$62,629
Maximum
$241,592
Average Salary
$140,503
LCA Filing History
H-1B LCA filing trends from FY2023 to FY2026
FY2023 115 LCA filings · 97.4% DOL-certified · $130,418 avg
FY2024 91 LCA filings · 100% DOL-certified · $136,896 avg
FY2025 114 LCA filings · 100% DOL-certified · $147,616 avg
FY2026 is partial on this extract. Chart shows completed fiscal years only (through FY2025).
Top Occupations
Most frequently listed job titles at Novartis Pharmaceuticals Corporation
| Job Title | LCA filings | Avg. Salary |
|---|---|---|
| Principal Biostatistician | 48 | $121,387 |
| Senior Principal Biostatistician | 24 | $128,626 |
| Expert Science & Technology | 7 | $113,690 |
| Principal Pharmacometrician | 5 | $110,852 |
| Associate Director, Biostatistics | 5 | $162,215 |
| Senior Principal Product Service Manager | 4 | $128,425 |
| Director, Resource Optimization Commercial | 4 | $223,142 |
| Process Engineer | 3 | $88,913 |
| Operational Health Project Manager | 3 | $134,070 |
| Manager, Business Analyst | 3 | $115,378 |
| Director, Predictive Analytics Solutions | 3 | $156,763 |
| Director, Medical Science Liaison | 3 | $145,690 |
| Clinical Trial Leader I | 3 | $109,706 |
| Associate Expert, Science and Technology | 3 | $74,554 |
| Associate Director, Analytical Data Solutions | 3 | $150,252 |
Geographic Distribution
Where Novartis Pharmaceuticals Corporation places H-1B workers across the United States
Nationwide peers near Novartis Pharmaceuticals Corporation's 382-LCA band
Cross-state DOL neighbors for Novartis Pharmaceuticals Corporation - LCA filing-count and offered-wage axes, outside NJ.
Similar LCA filing volume
Nearest cross-state employer filers by LCA filing count (382 here; floor ≥10 LCA filings).
Similar avg offered wage
Cross-state employer filers with a comparable average listed offered wage ($140,503 here).
Disclaimer: Informational only, not professional advice.
Read with Novartis Pharmaceuticals Corporation
ABS(total_petitions) peers first, then a LARGEST-distance pole and a stamp-branched drill, not a fixed Related strip. This page stamps MID-BOOK · CERT-CLEAN · WAGE-PREMIUM.
Appridat Solutions LLC · MID-BOOK
ABS(total_petitions) peer at 382 LCAs (Δ 0 heavier vs Novartis Pharmaceuticals Corporation); CERT-SOLID · WAGE-BELOW vs this page's MID-BOOK · CERT-CLEAN · WAGE-PREMIUM.
University of Oklahoma · MID-BOOK
ABS(total_petitions) peer at 382 LCAs (Δ 0 heavier vs Novartis Pharmaceuticals Corporation); CERT-SOLID · WAGE-BELOW vs this page's MID-BOOK · CERT-CLEAN · WAGE-PREMIUM.
The Huntington National Bank · MID-BOOK
ABS(total_petitions) peer at 383 LCAs (Δ 1 heavier vs Novartis Pharmaceuticals Corporation); CERT-SOLID · WAGE-PAR vs this page's MID-BOOK · CERT-CLEAN · WAGE-PREMIUM.
Zifo Technologies Inc. · MID-BOOK
ABS(total_petitions) peer at 381 LCAs (Δ 1 lighter vs Novartis Pharmaceuticals Corporation); CERT-LOCK · WAGE-BELOW vs this page's MID-BOOK · CERT-CLEAN · WAGE-PREMIUM.
Ernst & Young US LLP · LARGEST-distance pole
NJ pole at 39,678 LCAs stamps MEGA-BOOK · CERT-CLEAN, farthest ABS(total_petitions) contrast from Novartis Pharmaceuticals Corporation's MID-BOOK.
NJ worksite board · MID-BOOK
Open the NJ state board after the ABS peers. Novartis Pharmaceuticals Corporation stamps MID-BOOK · CERT-CLEAN inside that worksite mix.
Salary calculator · WAGE-PREMIUM
Novartis Pharmaceuticals Corporation's WAGE-PREMIUM offered-wage posture needs occupation/state context, not a shared guide card.
What to do with this profile
Use the DOL LCA record for Novartis Pharmaceuticals Corporation to compare filing volume and offered wages, not USCIS outcomes.
- Novartis Pharmaceuticals Corporation filed 382 LCAs in the indexed extract (99.2% certified in-file). That places it among the largest employer filers by volume in this extract.
- Compare offered wages and certification rates against 6 same-state filers on the chart above. Jump to compare
- See how other employers in NJ rank on LCA filing volume this vintage. NJ filers
- Read what an LCA filing records versus a USCIS petition approval. LCA vs petition
DOL disclosure data only. Not legal advice, sponsorship guarantees, or visa eligibility.
Every figure on PlainVisa is rendered directly from federal source data, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error. Data current as of 2026-09-09.